📰 Rom News
Page 531 - Rom News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Rom. Real-time updates on events, politics, business and more.
May 15, 2023
Gregor Kuglitsch from UBS retains his positive opinion on the stock with a Buy rating. The target price has been raised to EUR 80 from EUR 77. | May 15, 2023
May 15, 2023
AXA, Europes second-biggest insurance company, said first quarter sales rose 2% from the same period a year earlier, driven by its property and casualty policies. ... | May 15, 2023
May 15, 2023
Analyst Andreas Scheriau from Goldman Sachs research considers the stock attractive and recommends it with a Buy rating. The target price is being increased from EUR 17.40 to EUR 18.10. | May 15, 2023
May 15, 2023
Q1 2023 revenues of $17.4 million, a 15% increase from Q1 2022, driven by increased demand and strong execution Reaffirms expectations for total revenue of $95-100 million in 2023, a 24-31%... | May 15, 2023
May 15, 2023
In a research note published by Ben Andrews, Goldman Sachs advises its customers to buy the stock. The target price is revised upwards from GBX 18800 to GBX 13400. | May 15, 2023
May 15, 2023
Note: This document has been translated from the Japanese original for reference purposes only. In the event of any discrepancy between this translated document and the Japanese... | May 15, 2023
May 15, 2023
U.S. bank JPMorgan cut its price target for Merck KGaA to 225 euros from 250 euros after quarterly results, but kept its rating at Overweight. Analyst Richard Vosser reduced his sales and earnings... | May 15, 2023
May 15, 2023
Bangkok, Thailand - 15 May 2023 - Indorama Ventures Public Company Limited, a global sustainable chemical producer, was upgraded to "A" from "BBB" in MSCIs ESG... | May 15, 2023
May 15, 2023
JP Morgans research confirms his advice and maintains his neutral opinion on the stock. The target price is reduced from EUR 62 to EUR 55. | May 15, 2023
May 15, 2023
- Initiated CHORD™, a global Phase 1/2 dose escalation clinical trial of lead gene therapy product candidate, DB-OTO - - Announced approval from the U.K. MHRA and Spanish AEMPS for CTAs for... | May 15, 2023